aspirin has been researched along with medroxyprogesterone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Formelli, F; Mazzoni, A; Supino, R | 1 |
| Brown, G; Bunce, CM; Durham, J; French, PJ; Michell, RH; Mole, DJ; Mountford, JC | 1 |
| Barbour, MM | 1 |
| Altinoz, MA; Carin, MN; Gedikoglu, G; Ozdilli, K | 1 |
2 review(s) available for aspirin and medroxyprogesterone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hormone replacement therapy should not be used as secondary prevention of coronary heart disease.
Topics: Age Factors; Aged; Aspirin; Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medroxyprogesterone; Middle Aged; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism | 2000 |
6 other study(ies) available for aspirin and medroxyprogesterone
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Effect of medroxyprogesterone acetate and of some antiinflammatory agents on mouse erythroleukemia cell differentiation.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Anti-Inflammatory Agents; Aspirin; Cell Differentiation; Cell Line; Dexamethasone; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Flurbiprofen; Indomethacin; Leukemia, Erythroblastic, Acute; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Pyrazoles; Time Factors | 1984 |
Potentiation of myeloid differentiation by anti-inflammatory agents, by steroids and by retinoic acid involves a single intracellular target, probably an enzyme of the aldoketoreductase family.
Topics: 3-Hydroxysteroid Dehydrogenases; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Cell Differentiation; Cholecalciferol; Dexamethasone; Dihydrotestosterone; Down-Regulation; Estradiol; HL-60 Cells; Humans; Indomethacin; Medroxyprogesterone; Monocytes; Naphthol AS D Esterase; Neutrophils; Nitroblue Tetrazolium; Prostaglandins; Tretinoin | 1996 |
Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale.
Topics: Aspirin; Blood Transfusion, Intrauterine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobinopathies; Humans; Medroxyprogesterone; Models, Biological; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Third; Valproic Acid | 2007 |